GlaxoSmithKline Stock Price Prediction

<div class='circular--portrait' style='background:#754DEB;color: #F0FFF0;font-size:4em;padding-top: 25px;;'>GP</div>
GSK -- USA Stock  

Report: 22nd of July 2020  

GlaxoSmithKline PLC stock price prediction is an act of determining the future value of GlaxoSmithKline PLC shares using few different conventional methods such as EPS estimation, analyst consensus, or fundamental intrinsic valuation. The successful prediction of GlaxoSmithKline PLC stock future price could yield a significant profit. We analyze noise-free headlines and recent hype associated with GlaxoSmithKline PLC, which may create opportunities for some arbitrage if properly timed. Please check GlaxoSmithKline PLC Basic Forecasting Models to cross-verify your projections.

Search Stock Price Prediction

 
Refresh
It is a matter of debate whether stock price prediction based on information in financial news can generate a strong buy or sell signal. We use our internally-built news screening methodology to estimate the value of GlaxoSmithKline PLC based on different types of headlines from major news networks to social media. The GlaxoSmithKline stock price prediction module provides an analysis of price elasticity to changes in media outlook on GlaxoSmithKline PLC over a specific investment horizon. Using GlaxoSmithKline PLC hype-based prediction, you can estimate the value of GlaxoSmithKline PLC from the perspective of GlaxoSmithKline PLC response to recently generated media hype and the effects of current headlines on its competitors. GlaxoSmithKline PLC PPandE Turnover is increasing as compared to previous years. The last year's value of PPandE Turnover was reported at 3.15. The current Accounts Payable Turnover is estimated to increase to 10.13, while Cash and Equivalents Turnover is projected to decrease to 6.55.
This module is based on analyzing investor sentiment around taking a position in GlaxoSmithKline PLC. This speculative approach is based exclusively on the idea that markets are driven by emotions such as investor fear and greed. The fear of missing out, i.e., FOMO, can cause potential investors in GlaxoSmithKline PLC to buy its stock at a price that has no basis in reality. In that case, they are not buying GlaxoSmithKline because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell stocks at prices well below their value during bear markets because they need to stop feeling the pain of losing money.

GlaxoSmithKline PLC after-hype prediction price

 = 
40.65
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Earnings
Estimates (6)
LowProjected EPSHigh
2.832.902.98
Details
Intrinsic
Valuation
LowReal ValueHigh
36.6345.6446.98
Details
Naive
Forecast
LowNext ValueHigh
39.4540.7842.12
Details
11 Analysts
Consensus
LowTarget PriceHigh
42.1050.2758.00
Details

GlaxoSmithKline PLC After-Hype Price Prediction Density Analysis

As far as predicting the price of GlaxoSmithKline PLC at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in GlaxoSmithKline PLC or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many smart people who confused the symmetrical distributions of stock prices, such as prices of GlaxoSmithKline PLC, with the unreliable approximations that try to describe financial returns.
 Next price density 
      Expected price to next headline 

GlaxoSmithKline PLC Estimiated After-Hype Price Volatility

Current Value
40.70
15th of July 2020
40.65
After-hype Price
41.99
Upside
GlaxoSmithKline PLC is very steady asset. Analysis and calculation of next after-hype price of GlaxoSmithKline PLC is based on 3 months time horizon.

GlaxoSmithKline PLC Stock Price Prediction Analysis

Daily Expected returnPeriod VolatilityHype elasticityRelated hype elasticityAverage news densityRelated news densityNext Expected Hype
 0.03  1.34  0.05   0.01  8 Events / Month7 Events / MonthIn about 8 days
Latest traded priceExpected after-news pricePotential return on next major newsAverage after-hype volatility
40.7040.650.12 
82.72  

GlaxoSmithKline PLC Hype Timeline

On the 15th of July 2020 GlaxoSmithKline PLC is traded for 40.70. The entity has historical hype elasticity of -0.05 and average elasticity to hype of competition of -0.01. GlaxoSmithKline is forecasted to decline in value after the next headline with price expected to drop to 40.65. The average volatility ofmedia hypeimpact on the company stock price is about 82.72%. The price depreciation on the next newsis expected to be -0.12% whereas the daily expected return is currently at -0.03%. The volatility of related hype on GlaxoSmithKline PLC is about 370.17% with expected price after next announcement by competition of 40.69. The company last dividend was issued on the 14th of May 2020. GlaxoSmithKline PLC had 2:1 split on the 12th of November 1991. Considering the 30-days investment horizon, the next forecastedpress releasewill be in about 8 days.
Please check GlaxoSmithKline PLC Basic Forecasting Models to cross-verify your projections.

GlaxoSmithKline PLC Related Hype Analysis

Hype
Elasticity
News
Density
Semi
Deviation
Information
Ratio
Potential
Upside
Value
At Risk
Maximum
Drawdown
Astrazeneca PLC 0.52 7 per month 1.60  0.06  2.79 (3.27)  9.95 
Bristol Myers Squibb(3.19) 10 per month 0.00 (0.15)  2.04 (1.90)  8.37 
GlaxoSmithKline PLC(1.62) 8 per month 1.79 (0.07)  1.72 (2.10)  10.16 
Johnson Johnson 0.37 8 per month 1.13 (0.09)  1.99 (1.59)  9.17 
Eli Lilly And(4.26) 9 per month 1.36  0.0063  3.40 (2.37)  17.96 
Merck Company 1.59 12 per month 0.00 (0.14)  2.77 (2.99)  8.54 
Novartis AG(0.90) 34 per month 1.28 (0.10)  2.25 (1.84)  7.31 
Gilead Sciences 0.03 8 per month 2.36 (0.0321)  4.27 (4.01)  15.22 
Grifols S A(0.40) 10 per month 0.00 (0.10)  3.51 (2.90)  10.59 
GW Pharmaceuticals Plc 4.24 8 per month 1.92  0.17  4.90 (3.55)  10.56 

GlaxoSmithKline PLC Additional Predictive Modules

Most predictive techniques to examine GlaxoSmithKline stock price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for GlaxoSmithKline using various technical indicators. When you analyze GlaxoSmithKline charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.
Cycle Indicators
Math Operators
Math Transform
Momentum Indicators
Overlap Studies
Pattern Recognition
Price Transform
Statistic Functions
Volatility Indicators
Volume Indicators
Rate of change ratio
Relative Strength Index
Balance Of Power
Absolute Price Oscillator
Chande Momentum Oscillator
Plus Directional Movement
Commodity Channel Index
Aroon Oscillator
Directional Movement Index
Percentage Price Oscillator

About GlaxoSmithKline PLC Predictive Indicators

The successful prediction of GlaxoSmithKline PLC stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as GlaxoSmithKline PLC, already reflect all publically available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns on their portfolios. We use internally-developed statistical techniques to arrive at the intrinsic value of BlackBerry Limited based on analysis of GlaxoSmithKline PLC hews, social hype, and general headline patterns together with widely used predictive technical indicators. We also calculate exposure to GlaxoSmithKline PLC's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to GlaxoSmithKline PLC's related companies.
 2017 2019 2020 (projected)
Long Term Debt to Equity4.652.072.7
Interest Coverage5.68146.89158.48
Please check GlaxoSmithKline PLC Basic Forecasting Models to cross-verify your projections. Please also try Portfolio Suggestion module to get suggestions outside of your existing asset allocation including your own model portfolios.
Macroaxis is not a registered investment advisor or broker/dealer. All investments, including stocks, funds, ETFs, or cryptocurrencies, are speculative and involve substantial risk of loss. We encourage our investors to invest carefully. Much of our information is derived directly from data published by companies or submitted to governmental agencies which we believe are reliable, but are without our independent verification. Therefore, we cannot assure you that the information is accurate or complete. We do not in any way warrant or guarantee the success of any action you take in reliance on our statements or recommendations. Also, note that past performance is not necessarily indicative of future results. All investments carry risk, and all investment decisions of an individual remain the responsibility of that individual. There is no guarantee that systems, indicators, or signals will result in profits or that they will not result in losses. All investors are advised to fully understand all risks associated with any investing they choose to do. Hypothetical or simulated performance is not indicative of future results. We make no representations or warranties that any investor will, or is likely to, achieve profits similar to those shown because hypothetical or simulated performance is not necessarily indicative of future results. For more information please visit our terms and condition page